The current valuation score of Gilead Sciences Inc is 9.60, ranking 12 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 16.70, which is 5601.85% below the recent high of 951.96 and 6.59% above the recent low of 15.60.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.